Unternehmen
Pfizer Inc

Aktueller Kurs
36.7 USD

Symbol
PFE

ISIN
US7170811035

Börse
NYSE

Sektor
Health Care

Marktkapitalisierung
203.993 Mrd. US

Branche
Pharmaceuticals

Dividendenrendite
4.25 %

Ausschüttungsquote
53.68 %

KGV
23.86

KUV (TTM)
4.29

KGVe
11.64

Kursziel
41.79 USD

Unternehmen
Pfizer Inc

Aktueller Kurs
36.7 USD

Symbol
PFE

ISIN
US7170811035

Börse
NYSE

Marktkapitalisierung
203.993 Mrd. USD

Sektor
Health Care

Branche
Pharmaceuticals

Dividendenrendite
4.25 %

Ausschüttungsquote
53.68 %

KGV
23.86

KUV (TTM)
4.29

KGVe
11.64

Kursziel
41.79 USD

Live-Chart (verzögert)

Firmenbeschreibung

Pfizer Inc. develops, manufactures, and sells healthcare products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Sutent, Xtandi, Xalkori, Inlyta, Braftovi + Mektovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Vfend, and Zithromax brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, and tick-borne encephalitis under the Prevnar 13/Prevenar 13 (pediatric/adult), FSME-IMMUN, Nimenrix, and Trumenba brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, Genotropin, and Refacto AF/Xyntha brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company, Astellas Pharma US, Inc., and Myovant Sciences Ltd.; a licensing agreement with Akcea Therapeutics, Inc; a strategic alliance with Verily Life Sciences LLC; collaboration agreements with Merck KGaA and Valneva SE; a clinical trial collaboration and supply agreement with IDEAYA Biosciences, Inc.; collaboration agreement with BioNTech SE; a clinical supply collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd; a research collaboration and license agreement with BioInvent International AB; a drug discovery collaboration with Sosei Group Corporation; and collaboration with LianBio. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Pfizer Inc Fundamentaldaten

Jahre und Quartale beziehen sich jeweils auf das Geschäftsjahr des Unternehmens. (Das Geschäftsjahr kann ggf. vom Kalenderjahr abweichen.)

Das Geschäftsjahr von Pfizer Inc endet im Dezember.

Gewinn pro Jahr & Quartal (Net Income) in Mrd. USD

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.000 0.000 0.000 0.000 0.000
2020 3.401 3.426 2.194 0.000 9.021
2019 3.884 5.046 7.680 -0.337 16.273
2018 3.561 3.872 4.114 -0.394 11.153
2017 3.121 3.073 2.840 12.274 21.308
2016 3.016 2.019 1.320 0.860 7.215
2015 2.376 2.626 2.130 -0.172 6.960
2014 2.329 2.912 2.666 1.228 9.135
2013 2.750 14.095 2.590 2.568 22.003
2012 1.794 3.253 3.208 6.315 14.570
2011 2.222 2.610 3.738 1.439 10.009
2010 2.026 2.475 0.866 2.890 8.257

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 0.8 0.78 0.72 0 2.3
2019 0.85 0.8 0.75 0.55 2.95
2018 0.77 0.81 0.78 0.64 3
2017 0.69 0.67 0.67 0.62 2.65
2016 0.67 0.64 0.61 0.47 2.39
2015 0.51 0.56 0.6 0.53 2.2
2014 0.57 0.58 0.57 0.54 2.26
2013 0.54 0.56 0.58 0.56 2.24
2012 0.58 0.62 0.53 0.47 2.2
2011 0.6 0.6 0.62 0.5 2.32
2010 0.6 0.62 0.54 0.47 2.23

Umsatz pro Jahr & Quartal in Mrd. USD

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 12.028 11.801 12.131 0 35.96
2019 13.118 13.264 12.68 12.688 51.75
2018 12.906 13.466 13.298 13.977 53.647
2017 12.779 12.896 13.168 13.703 52.546
2016 13.005 13.147 13.045 13.627 52.824
2015 10.864 11.853 12.087 14.047 48.851
2014 11.353 12.773 12.361 13.118 49.605
2013 13.5 12.973 12.643 12.468 51.584
2012 15.405 15.057 13.976 14.548 58.986
2011 16.502 16.984 17.193 16.746 67.425
2010 16.75 17.327 16.171 17.561 67.809

Umsatz je Aktie pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 2.14 2.10 2.15 0.00 99.61
2019 2.28 2.34 2.24 2.24 9.12
2018 2.13 2.26 2.22 2.34 8.98
2017 2.10 2.14 2.18 2.26 8.67
2016 2.09 2.14 2.12 2.21 8.58
2015 1.73 1.90 1.94 2.25 7.81
2014 1.75 1.98 1.93 2.04 7.72
2013 1.86 1.82 1.90 1.81 7.48
2012 2.03 2.00 1.86 1.94 7.86
2011 2.05 2.14 2.20 2.13 8.57
2010 2.07 2.15 2.01 2.18 8.40

Gewinn-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 -100.00
2020 0.00 0.74 -35.96 -100.00 -44.56
2019 0.00 29.92 52.20 -104.39 45.91
2018 -70.99 8.73 6.25 -109.58 -47.66
2017 262.91 -1.54 -7.58 332.18 195.33
2016 0.00 -33.06 -34.62 -34.85 3.66
2015 93.49 10.52 -18.89 -108.08 -23.81
2014 -9.31 25.03 -8.45 -53.94 -58.48
2013 -56.45 412.55 -81.62 -0.85 51.02
2012 24.67 81.33 -1.38 96.85 45.57
2011 -23.11 17.46 43.22 -61.50 21.22
2010 164.15 22.16 -65.01 233.72 -4.38

Umsatz-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 -5.20 -1.89 2.80 0.00 0.00
2019 -6.15 1.11 -4.40 0.06 -3.54
2018 -5.82 4.34 -1.25 5.11 2.10
2017 -6.22 0.92 2.11 4.06 -0.53
2016 -7.42 1.09 -0.78 4.46 8.13
2015 -17.18 9.10 1.97 16.22 -1.52
2014 -8.94 12.51 -3.23 6.12 -3.84
2013 -7.20 -3.90 -2.54 -1.38 -12.55
2012 -8.01 -2.26 -7.18 4.09 -12.52
2011 -6.03 2.92 1.23 -2.60 -0.57
2010 1.39 3.44 -6.67 8.60 35.70

Pfizer Inc Fundamentaldaten

Gewinn pro Jahr & Quartal (Net Income)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.000 0.000 0.000 0.000 0.000
2020 3.401 3.426 2.194 0.000 9.021
2019 3.884 5.046 7.680 -0.337 16.273
2018 3.561 3.872 4.114 -0.394 11.153
2017 3.121 3.073 2.840 12.274 21.308
2016 3.016 2.019 1.320 0.860 7.215
2015 2.376 2.626 2.130 -0.172 6.960
2014 2.329 2.912 2.666 1.228 9.135
2013 2.750 14.095 2.590 2.568 22.003
2012 1.794 3.253 3.208 6.315 14.570
2011 2.222 2.610 3.738 1.439 10.009
2010 2.026 2.475 0.866 2.890 8.257

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 0.8 0.78 0.72 0 2.3
2019 0.85 0.8 0.75 0.55 2.95
2018 0.77 0.81 0.78 0.64 3
2017 0.69 0.67 0.67 0.62 2.65
2016 0.67 0.64 0.61 0.47 2.39
2015 0.51 0.56 0.6 0.53 2.2
2014 0.57 0.58 0.57 0.54 2.26
2013 0.54 0.56 0.58 0.56 2.24
2012 0.58 0.62 0.53 0.47 2.2
2011 0.6 0.6 0.62 0.5 2.32
2010 0.6 0.62 0.54 0.47 2.23

Umsatz pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 12.028 11.801 12.131 0 35.96
2019 13.118 13.264 12.68 12.688 51.75
2018 12.906 13.466 13.298 13.977 53.647
2017 12.779 12.896 13.168 13.703 52.546
2016 13.005 13.147 13.045 13.627 52.824
2015 10.864 11.853 12.087 14.047 48.851
2014 11.353 12.773 12.361 13.118 49.605
2013 13.5 12.973 12.643 12.468 51.584
2012 15.405 15.057 13.976 14.548 58.986
2011 16.502 16.984 17.193 16.746 67.425
2010 16.75 17.327 16.171 17.561 67.809

Umsatz je Aktie pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 2.14 2.10 2.15 0.00 99.61
2019 2.28 2.34 2.24 2.24 9.12
2018 2.13 2.26 2.22 2.34 8.98
2017 2.10 2.14 2.18 2.26 8.67
2016 2.09 2.14 2.12 2.21 8.58
2015 1.73 1.90 1.94 2.25 7.81
2014 1.75 1.98 1.93 2.04 7.72
2013 1.86 1.82 1.90 1.81 7.48
2012 2.03 2.00 1.86 1.94 7.86
2011 2.05 2.14 2.20 2.13 8.57
2010 2.07 2.15 2.01 2.18 8.40

Gewinn-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 -100.00
2020 0.00 0.74 -35.96 -100.00 -44.56
2019 0.00 29.92 52.20 -104.39 45.91
2018 -70.99 8.73 6.25 -109.58 -47.66
2017 262.91 -1.54 -7.58 332.18 195.33
2016 0.00 -33.06 -34.62 -34.85 3.66
2015 93.49 10.52 -18.89 -108.08 -23.81
2014 -9.31 25.03 -8.45 -53.94 -58.48
2013 -56.45 412.55 -81.62 -0.85 51.02
2012 24.67 81.33 -1.38 96.85 45.57
2011 -23.11 17.46 43.22 -61.50 21.22
2010 164.15 22.16 -65.01 233.72 -4.38

Umsatz-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 -5.20 -1.89 2.80 0.00 0.00
2019 -6.15 1.11 -4.40 0.06 -3.54
2018 -5.82 4.34 -1.25 5.11 2.10
2017 -6.22 0.92 2.11 4.06 -0.53
2016 -7.42 1.09 -0.78 4.46 8.13
2015 -17.18 9.10 1.97 16.22 -1.52
2014 -8.94 12.51 -3.23 6.12 -3.84
2013 -7.20 -3.90 -2.54 -1.38 -12.55
2012 -8.01 -2.26 -7.18 4.09 -12.52
2011 -6.03 2.92 1.23 -2.60 -0.57
2010 1.39 3.44 -6.67 8.60 35.70

Pfizer Inc Dividenden-Entwicklung

Ex-Tag Record Date Zahltag Dividende
2021-01-28 2021-01-29 2021-03-05 0.39
2020-11-05 2020-11-06 2020-12-01 0.38
2020-07-30 2020-07-31 2020-09-01 0.38
2020-05-07 2020-05-08 2020-06-05 0.38
2020-01-30 2020-01-31 2020-03-06 0.38
2019-11-07 2019-11-08 2019-12-02 0.36
2019-08-01 2019-08-02 2019-09-03 0.36
2019-05-09 2019-05-10 2019-06-07 0.36
2019-01-31 2019-02-01 2019-03-01 0.36
2018-11-08 2018-11-09 2018-12-03 0.34
2018-08-02 2018-08-03 2018-09-04 0.34
2018-05-10 2018-05-11 2018-06-01 0.34
2018-02-01 2018-02-02 2018-03-01 0.34
2017-11-09 2017-11-10 2017-12-01 0.32
2017-08-02 2017-08-04 2017-09-01 0.32
2017-05-10 2017-05-12 2017-06-01 0.32
2017-02-01 2017-02-03 2017-03-01 0.32
2016-11-08 2016-11-11 2016-12-01 0.3
2016-08-03 2016-08-05 2016-09-01 0.3
2016-05-11 2016-05-13 2016-06-01 0.3